Evaluation of CD44 and CD133 as markers of liver cancer stem cells in Egyptian patients with HCV-induced chronic liver diseases versus hepatocellular carcinoma.
about
Evaluation of CD44 and CD133 as markers of liver cancer stem cells in Egyptian patients with HCV-induced chronic liver diseases versus hepatocellular carcinoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Evaluation of CD44 and CD133 a ...... rsus hepatocellular carcinoma.
@en
type
label
Evaluation of CD44 and CD133 a ...... rsus hepatocellular carcinoma.
@en
prefLabel
Evaluation of CD44 and CD133 a ...... rsus hepatocellular carcinoma.
@en
P2093
P2860
P1433
P1476
Evaluation of CD44 and CD133 a ...... rsus hepatocellular carcinoma.
@en
P2093
Ahmed Abdelaleem Abo el Hassan
Ahmed Ibrahim El-Shabasy
Ali Abdel Rahim
Ali Ibrahim Ali
Amgad Anas
Heba Khalil
Mohammed Saeed Rozeik
Mona Magdy
Olfat Ali Hammam
P2860
P304
P577
2017-07-25T00:00:00Z